Overexpression of BCL2 in chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL) cells renders these cancer cells resistant to chemotherapy [36]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.